Vivo Capital, a global healthcare investment firm, completed its investment in Seran BioScience, a manufacturing firm providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies. Financial terms were not disclosed. "Seran has built an exceptional organization that is predicated on technical excellence, science-driven decision-making, and an unwavering commitment to quality and customer service. Seran's specialized expertise in enhanced solubility and engineered particle formulations enables solutions to some of the most difficult challenges in drug development. We look forward to supporting founders Dan and John in the journey ahead," Mahendra Shah, Vivo Managing Director.